Non-invasive methods to diagnose complications after liver transplantation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of non-invasive methods to identify postoperative complications in liver transplant recipients. It focuses on the early detection of acute cellular rejection and early allograft dysfunction by analyzing biological markers and instrumental assessments. The goal is to improve prognostic capabilities in the early post-transplant phase, addressing a significant gap in current diagnostic practices. By monitoring liver enzyme levels and function tests, the study aims to enhance patient outcomes following liver transplantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients eligible for liver transplantation following National and International Guidelines

Exclusion Criteria:

* No agreement or inability to give informed consent

  * Re-transplant patients
  * Liver transplant in fulminant hepatitis

Where it's running

• Fondazione Policlinico Universitario A. Gemelli IRCCS
  Rome, Italy Recruiting

Study contacts

• Study coordinator: Luca Miele, MD, PhD
• Email: luca.miele@policlinicogemelli.it
• Phone: +390630151

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transplanting abdominal wall tissue to repair defects

  This study is testing if transplanting abdominal wall tissue can safely fix defects in the abdominal area for people who need it.

  Recruiting Duke University · Durham, North Carolina · NCT03310905

• Assessing diabetes risk in cirrhosis patients before and after liver transplant

  This study is trying to find out what factors might lead to diabetes in adults with liver cirrhosis before and after they get a liver transplant.

  Recruiting University of Chicago · Chicago, Illinois · NCT06950788

• XVIVO Heart Box non-ischemic preservation for transporting donor hearts.

  This program tests whether the XVIVO non-ischemic heart preservation system can safely preserve extended-criteria donor hearts for adults waiting for a heart transplant.

  Recruiting at 14 sites XVIVO Perfusion · La Jolla, California and 13 other locations · NCT06895070

• Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Personalization of Immunosuppression

  This study tests whether non-invasive biomarkers can guide care in kids with kidney transplants to reduce biopsies and tailor immunosuppressive drug exposure.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06761482

• Using spleen stiffness measurement to predict outcomes in liver disease patients with acute liver injury

  This study is testing if measuring spleen stiffness can help predict how patients with chronic liver disease and acute liver injury will do in the short term.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT06173947

• Using high-dose insulin therapy to enhance liver function before surgery

  This study is testing if high-dose insulin therapy can help improve liver function in patients who are about to have major liver surgery.

  Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT06126419

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.